Clinical Benefit From Pemetrexed Before and After Crizotinib Exposure and From Crizotinib Before and After Pemetrexed Exposure in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer
Eamon M Berge, Xian Lu, Delee Maxson, Anna E Baron, Shirish M Gadgeel, Benjamin J Solomon, Robert C Doebele, Maria Varella-Garcia, D Ross Camidge
Clinical Lung Cancer | CIG MEDIA GROUP, LP | Published : 2013
D.R.C.: Consultation roles and honoraria from Pfizer and Eli Lilly. R.C.D.: Consultation roles and honoraria from Pfizer and research grants from Eli Lilly and Pfizer. All other authors have no conflicts of interest.